ProfileGDS4132 / 204922_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 27% 30% 27% 26% 31% 27% 26% 28% 25% 29% 20% 20% 24% 27% 21% 21% 20% 26% 22% 22% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10164.75227
GSM201543Muscle PCOS pioglitazone 12165.077730
GSM201544Muscle PCOS pioglitazone 16166.746527
GSM201545Muscle PCOS pioglitazone 20170.594126
GSM201829Muscle PCOS pioglitazone 23181.505431
GSM201830Muscle PCOS pioglitazon 25166.925427
GSM201831Muscle PCOS pioglitazone 27158.051526
GSM201832Muscle PCOS pioglitazone 3169.815328
GSM201833Muscle PCOS pioglitazone 4154.607825
GSM201834Muscle PCOS pioglitazone 8168.484829
GSM201835Muscle PCOS after pioglitazone 10233.834720
GSM201836Muscle PCOS after pioglitazone 12235.672520
GSM201837Muscle PCOS after pioglitazone 16243.901924
GSM201838Muscle PCOS after pioglitazone 20256.797827
GSM201839Muscle PCOS after pioglitazone 23240.88121
GSM201840Muscle PCOS after pioglitazone 25245.313421
GSM201841Muscle PCOS after pioglitazone 27233.355620
GSM201842Muscle PCOS after pioglitazone 3249.295626
GSM201843Muscle PCOS after pioglitazone 4249.922822
GSM201844Muscle PCOS after pioglitazone 8244.922322